October 26, 2021
RFA-NS-21-029 - HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in RFA-NS-21-029 - "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)".
The following sections of RFA-NS-21-029 have been modified to highlight NHLBI's participation in this FOA:
Currently Reads:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
Assistance Listing Number(s)
93.853, 93.242, 93.273, 93.846, 93.213, 93.865, 93.866, 93.121, 93.867
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
National Heart, Lung, and Blood Institute (NHLBI)
Assistance Listing Number(s)
93.853, 93.242, 93.273, 93.846, 93.213, 93.865, 93.866, 93.121, 93.867, 93.839, 93.837, 93.838, 93.840, 93.233
Section VII. Agency Contacts
Scientific/Research Contact(s)
Asif Rizwan, PhD
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0070
E-mail: asif.rizwan@nih.gov
Financial/Grants Management Contact(s)
Nina Hall
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-827-2393
E-mail: nina.hall@nih.gov
Asif Rizwan, PhD
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0070
E-mail: asif.rizwan@nih.gov